Kai Hong Yuan
Chairman chez JIANGSU HENGRUI MEDICINE CO., LTD.
Fortune : 8 M $ au 31/03/2024
Profil
Kai Hong Yuan is currently the Chairman-Supervisory Board at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
and also holds the position of Director at Tibet Dayuan Investment Co., Ltd.
He completed his undergraduate degree from China Pharmaceutical University in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/11/2022 | 1 260 000 ( 0,02% ) | 8 M $ | 31/03/2024 |
Postes actifs de Kai Hong Yuan
| Sociétés | Poste | Début |
|---|---|---|
| JIANGSU HENGRUI MEDICINE CO., LTD. | Chairman | 02/02/2023 |
Tibet Dayuan Investment Co., Ltd.
 Tibet Dayuan Investment Co., Ltd. Financial ConglomeratesFinance Tibet Dayuan Investment Co., Ltd. engages in the provision of investment services. Its business activities include industrial investment, investment management, and investment advisory services. The company was founded on July 12, 2005 and is headquartered in Lhasa, China. | Director/Board Member | - |
Formation de Kai Hong Yuan
| China Pharmaceutical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Tibet Dayuan Investment Co., Ltd.
Tibet Dayuan Investment Co., Ltd. Financial ConglomeratesFinance Tibet Dayuan Investment Co., Ltd. engages in the provision of investment services. Its business activities include industrial investment, investment management, and investment advisory services. The company was founded on July 12, 2005 and is headquartered in Lhasa, China. | Finance |
